Published in J Neurol Neurosurg Psychiatry on June 05, 2008
Management of ischaemic stroke in the acute setting: review of the current status. Cardiovasc J Afr (2013) 0.97
Recommendations for management of patients with carotid stenosis. Stroke Res Treat (2012) 0.87
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study. BMJ (2015) 0.85
Personalized medicine and stroke prevention: where are we? Vasc Health Risk Manag (2015) 0.78
Antiplatelet therapy in secondary stroke prevention--state of the art. J Cell Mol Med (2010) 0.76
Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST). Trials (2015) 0.76
Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack. Stroke Res Treat (2017) 0.75
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001) 5.18
Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia (2012) 4.82
European principles of management of common headache disorders in primary care. J Headache Pain (2007) 4.77
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke (1999) 2.49
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology (2009) 2.40
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke (2000) 2.33
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke (1998) 2.23
Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia (2013) 2.19
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation (1995) 2.13
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Practical experiences on the necessity of external validation. Stat Med (2007) 2.09
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
Pentoxifylline in acute nonhemorrhagic stroke. A randomized, placebo-controlled double-blind trial. Stroke (1988) 2.05
Ticlopidine, trials, and torture. Stroke (1994) 2.04
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry (1999) 2.03
Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract (2005) 2.01
Migraine, headache, and the risk of stroke in women: a prospective study. Neurology (2005) 2.01
Features of medication overuse headache following overuse of different acute headache drugs. Neurology (2002) 1.93
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain (2005) 1.85
Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke (1998) 1.82
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation (1999) 1.69
Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68
Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology (2007) 1.64
Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia (2012) 1.63
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Neurology (2000) 1.63
Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ (1995) 1.62
Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology (2007) 1.62
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol (2012) 1.60
Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Br J Pharmacol (2009) 1.60
Outcome in familial subarachnoid hemorrhage. Stroke (1995) 1.59
Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia (2007) 1.59
Quality of life after severe bacterial peritonitis and infected necrotizing pancreatitis treated with open management of the abdomen and planned re-operations. Crit Care Med (2001) 1.56
The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost (2003) 1.55
Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. Circulation (1996) 1.54
Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology (2007) 1.54
Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry (2005) 1.53
Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review. Diabet Med (2013) 1.51
Quality of life after infrainguinal bypass grafting surgery. Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group. J Vasc Surg (1999) 1.49
Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke (1997) 1.49
Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology (1996) 1.48
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol (2001) 1.46
Predicting outcome after acute basilar artery occlusion based on admission characteristics. Neurology (2012) 1.45
Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand (2000) 1.45
Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology (2004) 1.44
Fou rire prodromique heralding a left internal carotid artery occlusion. Stroke (1997) 1.44
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ (2011) 1.44
Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A. J Infect Dis (1993) 1.42
Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurology (1989) 1.42
Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry (2005) 1.40
[20,000 kg aspirin and 45 pages British Medical Journal]. Ned Tijdschr Geneeskd (1994) 1.40
Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J Neurol Neurosurg Psychiatry (1998) 1.39
[Chronicle of a defective heart valve prosthesis]. Ned Tijdschr Geneeskd (1998) 1.39
Restriction fragment length polymorphism of the apoprotein A-I-C-III gene cluster in control and stroke-prone white and black subjects: racial differences. Stroke (1992) 1.39
[Surgery for a recently symptomatic severe carotid stenosis, indicated or not? Clinical application of 'evidence-based' medicine]. Ned Tijdschr Geneeskd (2001) 1.39
[Carotid endarterectomy indicated in asymptomatic stenosis]. Ned Tijdschr Geneeskd (2004) 1.38
['Neurodevelopmental treatment' following stroke: no beneficial effect shown in measurements taken after 1 year; comparative study]. Ned Tijdschr Geneeskd (2007) 1.38
Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry (1992) 1.38
Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology (1996) 1.38
The prognostic value of domain-specific cognitive abilities in acute first-ever stroke. Neurology (2005) 1.36
Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia (2013) 1.36
Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol (1999) 1.35
Risk factors for subarachnoid hemorrhage: a systematic review. Stroke (1996) 1.35
Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol (2000) 1.35
Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event. J Neurol Neurosurg Psychiatry (2007) 1.35
Development and validation of the Essen Intracerebral Haemorrhage Score. J Neurol Neurosurg Psychiatry (2005) 1.34
Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt. Cerebrovasc Dis (2009) 1.34
Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (1999) 1.30
Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost (2005) 1.29
Patient-centered yes/no prognosis using learning machines. Int J Data Min Bioinform (2008) 1.26
Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol (1992) 1.23
Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.23
Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST). J Neurol Neurosurg Psychiatry (2005) 1.21
The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus. Diabet Med (2010) 1.20
Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke (1998) 1.19
Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis. Br J Surg (1997) 1.18
[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial]. Rev Neurol (Paris) (1982) 1.18
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology (2000) 1.16
Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2004) 1.16